Literature DB >> 21352715

A simple method to treat post-kydney transplantation lymphocele.

G Damiano1, C Lombardo, V D Palumbo, D Buffa, C Maione, M C Gioviale, F Cacciabaudo, G Spinelli, C Calvagna, A I Lo Monte.   

Abstract

OBJECTIVE: To describe our experience with ultrasonic-guided instillation of povidone-iodine to treat post-kidney transplantation lymphocele. Patients and methods. We studied the safety and efficacy of this procedure for treatment of lymphocele in 6 male kidney transplanted recipients in which we assisted a progressive increase of creatinine and urinary proteins levels and color-Doppler ultrasonography demonstrated an increase (25,4%) of index of resistence (IR) Using eco-colorDoppler, the related-graft lymphocele location and the distance to the anterior abdominal wall were determined; then, a radiopaque double-lumen catheter was used to instillate 5% povidone-iodine 10 ml. Results. Percutaneous drainage achieved a resolution rate of 100%. Studying the rate of peripheral and internal vascularization of the kidney before and after treatment, eco-colorDoppler showed a significant decrease of the IR (24,6%). Conclusions. The US-guided povidone-iodine instillation for treatment of lymphocele following renal transplantation may be considered as first choice therapy in such disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352715

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  2 in total

1.  Povidone-iodine sclerotherapy of primary symptomatic lymphocele after kidney transplantation.

Authors:  Michael Baboudjian; Abel Tadrist; Bastien Gondran-Tellier; Robin McManus; Akram Akiki; Sarah Gaillet; Veronique Delaporte; Ana Carballeira; Marc Andre; Gilles Karsenty; Eric Lechevallier; Romain Boissier
Journal:  Int Urol Nephrol       Date:  2020-11-10       Impact factor: 2.370

2.  Investigation of treatment efficacy of 10% povidone–iodine sclerotherapy on ovarian cyst diameter: an experimental study

Authors:  Remzi Atılgan; Şehmus Pala; Tuncay Kuloğlu
Journal:  Turk J Med Sci       Date:  2019-06-18       Impact factor: 0.973

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.